Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Julie M Shabto"'
Autor:
Yuan Liu, Haydn Kissick, Viraj A Master, Mehmet Asim Bilen, Dylan Martini, Lauren Yantorni, Sarah Caulfield, Bassel Nazha, Omer Kucuk, Deepak Ravindranathan, Kenneth Ogan, Jacqueline T Brown, Julie M Shabto, Emilie Elise Hitron, Greta Anne Russler, Shreyas Subhash Joshi, Bradley C Carthon, Wayne B Harris
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background The modified Glasgow Prognostic Score (mGPS) is a composite biomarker that uses albumin and C reactive protein (CRP). There are multiple immune checkpoint inhibitor (ICI)-based combinations approved for metastatic renal cell carcinoma (mRC
Externí odkaz:
https://doaj.org/article/4f2dc748bda445bcbb2fb153c0efb1a8
Publikováno v:
BMC Surgery, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background In concordance with medical recommendations in response to COVID-19, Emory Healthcare limited surgical procedures starting March 16, 2020. We investigated the impact of these recommendations on the number, types, and urgency of su
Externí odkaz:
https://doaj.org/article/c283c440570049b595da05d6aee2789a
Autor:
Julie M. Shabto, Dylan J. Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline Brown, Emilie E. Hitron, Greta A. Russler, Sarah Caulfield, Haydn Kissick, Mehrdad Alemozaffar, Kenneth Ogan, Wayne B. Harris, Viraj A. Master, Omer Kucuk, Bradley C. Carthon, Mehmet A. Bilen
Publikováno v:
Cancer Medicine, Vol 9, Iss 8, Pp 2752-2760 (2020)
Abstract Background We developed a novel risk scoring system for urothelial cancer (UC) patients receiving immune checkpoint inhibitors (ICI). Methods We conducted a retrospective review of 67 UC patients treated with ICI at Winship Cancer Institute
Externí odkaz:
https://doaj.org/article/c4c3b05ccaa44df48e328161b5208ced
Autor:
Mehmet Asim Bilen, Julie M. Shabto, Dylan J. Martini, Yuan Liu, Colleen Lewis, Hannah Collins, Mehmet Akce, Haydn Kissick, Bradley C. Carthon, Walid L. Shaib, Olatunji B. Alese, Conor E. Steuer, Christina Wu, David H. Lawson, Ragini Kudchadkar, Viraj A. Master, Bassel El-Rayes, Suresh S. Ramalingam, Taofeek K. Owonikoko, R. Donald Harvey
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Selecting the appropriate patients to receive immunotherapy (IO) remains a challenge due to the lack of optimal biomarkers. The presence of liver metastases has been implicated as a poor prognostic factor in patients with metastat
Externí odkaz:
https://doaj.org/article/3a89538b1b6f4594bd638b17c5ad5f05
Autor:
Dylan J. Martini, Meredith R. Kline, Yuan Liu, Julie M. Shabto, Bradley C. Carthon, Greta Anne Russler, Lauren Yantorni, Emilie Elise Hitron, Sarah Caulfield, Jamie M. Goldman, Wayne B. Harris, Omer Kucuk, Viraj A Master, Mehmet Asim Bilen
Publikováno v:
Cancer Treatment and Research Communications, Vol 28, Iss , Pp 100393- (2021)
Background: Cabozantinib is an effective treatment for metastatic renal cell carcinoma (mRCC). The international mRCC database consortium (IMDC) criteria is the gold standard for risk stratification in mRCC. We created a risk scoring system specific
Externí odkaz:
https://doaj.org/article/88cfc89656924a159ed5e19c6f52d91b
Autor:
Julie M. Shabto, Dattatraya Patil, Katherine Poulose, Mackenzie P. Bennett, Angel X. Xiao, Heather S. Hipp, Jennifer F. Kawwass, Akanksha Mehta
Publikováno v:
Urology Practice. 9:321-330
Autor:
Greta Russler, Bassel Nazha, Sarah Caulfield, Mehmet Asim Bilen, Yuan Liu, Bradley C. Carthon, Sean Evans, Wayne Harris, Omer Kucuk, Jacqueline T. Brown, Viraj A. Master, Jamie M. Goldman, Dylan J. Martini, Lauren Yantorni, Ogul E. Uner, T. Anders Olsen, Julie M. Shabto
Publikováno v:
Clin Genitourin Cancer
Background : Full dose cabozantinib for metastatic renal cell carcinoma (mRCC) is 60mg, but adverse events (AEs) may require dose reductions. Limited data exist comparing efficacy among cabozantinib doses. We compared AEs and clinical outcomes in mRC
Autor:
Kenneth Ogan, Greta Russler, Jamie M. Goldman, Bassel Nazha, Benjamin Magod, Bradley C. Carthon, Deepak Ravindranathan, Shreyas S. Joshi, Haydn T. Kissick, Yuan Liu, T. Anders Olsen, Wayne Harris, Julie M. Shabto, Omer Kucuk, Jacqueline T. Brown, Subir Goyal, Sarah Caulfield, Lauren Yantorni, Mehmet Asim Bilen, Viraj A. Master, Sean Evans, Dylan J. Martini
Publikováno v:
Oncologist
Background Several immune checkpoint inhibitors (ICIs) are approved for the treatment of advanced urothelial carcinoma (UC). There are limited biomarkers for ICI-treated patients with UC. We investigated the association between body composition and c
Autor:
Yuan Liu, Julie M. Shabto, Bradley C. Carthon, Lauren Yantorni, Viraj A. Master, Dylan J. Martini, Omer Kucuk, Kenneth Ogan, Mehmet Asim Bilen, Shreyas S. Joshi, Jacqueline T. Brown, Deepak Ravindranathan, Wayne Harris, Sarah Caulfield, Haydn T. Kissick, Emilie Elise Hitron, Greta Russler
Publikováno v:
Oncologist
Background The modified Glasgow prognostic score (mGPS), a clinical tool that incorporates albumin and C-reactive protein, has proven useful in the prognostication of multiple cancers. Several immune checkpoint inhibitors (ICIs) have been approved fo
Publikováno v:
Journal of Glaucoma
This review focuses on best practices and recommendations for hygiene and disinfection to limit exposure and transmission of infection in outpatient glaucoma clinics during the current COVID-19 pandemic.